Bavarian Nordic A/S : Bavarian Nordic to Present at Biotech Showcase 2013 in San Francisco

 Bavarian Nordic A/S : Bavarian Nordic to Present at Biotech Showcase 2013 in
                                San Francisco

KVISTGAARD, Denmark, January 3, 2013 - Bavarian Nordic (NASDAQ OMX: BAVA)
announced today that Anders Hedegaard, President & CEO will present at the
Biotech Showcase(TM) 2013 Conference in San Francisco, CA on Monday, January
7, 2013 at 11:30 am PST.

The presentation slides will subsequently be available on the company's

Biotech Showcase is an investor and partnering conference devoted to providing
private and public biotechnology and life sciences companies an opportunity to
present to, and meet with, investors and pharmaceutical executives during the
course of one of the industry's largest annual healthcare investor
conferences. The conference is taking place at Parc 55 Wyndham San Francisco -
Union Square Hotel.

Rolf Sass Sørensen, Vice President Investor Relations & Communications
Phone: +45 33 26 83 83

About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline targets
cancer and infectious diseases, and includes ten development programs. In
oncology, the company's lead program is PROSTVAC®, a therapeutic vaccine
candidate for advanced prostate cancer that is the subject of an ongoing
pivotal Phase 3 trial and is being developed under a collaboration agreement
with the National Cancer Institute. In clinical Phase 1 and Phase 2 trials,
PROSTVAC® has been tested in nearly 600 patients. In infectious diseases, the
company's lead program is IMVAMUNE®, a non-replicating smallpox vaccine
candidate that is being developed and supplied for emergency use to the U.S.
Strategic National Stockpile under a contract with the U.S. Government. For
more information, visit


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Bavarian Nordic A/S via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.